NCT00537485View on ClinicalTrials.gov

A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Early Parkinson's Disease
Interventions
DRUG

SPM 962

transdermal application, 1 time per day

DRUG

placebo

transdermal application, 1 time per day

Trial Locations (6)

Unknown

Chubu Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY